Baylor update: outcome analysis in liver transplantation.
An analysis of the first 740 liver transplants performed at Baylor is presented, including all cases to the end of calendar 1992. Kaplan-Meier curves are extended to nine years posttransplant. Our focus on outcome analysis has led us to review our experience with diabetics, with elderly patients, causes and patterns of late graft loss, long-term renal function. Quality of life data tracked for 2 years posttransplant is outlined. Clinical correlates to whole blood and plasma assays of FK506 are reviewed. Concerns remain over the disappointing results of liver transplantation for cholangiocarcinoma and those of patients with hepatitis-B antigenemia under current protocols.
Levy
M F
MF
Baylor University Medical Center, Dallas, Texas.
Goldstein
R M
RM
Husberg
B S
BS
Gonwa
T A
TA
Backman
L
L
Abouljoud
M
M
Mulligan
D
D
Klintmalm
G B
GB
D000046:Academic Medical Centers; D000328:Adult; D003920:Diabetes Mellitus / Q000401:mortality; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007165:Immunosuppression Therapy; D008107:Liver Diseases / Q000601:surgery; D016031:Liver Transplantation / Q000502:physiology / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D009017:Morbidity; D011788:Quality of Life; D013781:Texas / Q000453:epidemiology; D016896:Treatment Outcome